Shopping Cart
- Remove All
Your shopping cart is currently empty
IOX5 is a selective prolyl hydroxylase (PHD) inhibitor with an IC50 of 0.19 μM for PHD2. In acute myeloid leukemia (AML) cells, IOX5 can stabilize HIF-1α, inhibit cell proliferation, and induce apoptosis. It exhibits anti-leukemia activity.

| Description | IOX5 is a selective prolyl hydroxylase (PHD) inhibitor with an IC50 of 0.19 μM for PHD2. In acute myeloid leukemia (AML) cells, IOX5 can stabilize HIF-1α, inhibit cell proliferation, and induce apoptosis. It exhibits anti-leukemia activity. |
| In vitro | IOX5 (0.5-100 μM; 24-96 hours) stabilizes the expression of HIF-1α in AML cell lines, inhibiting cell proliferation and inducing apoptosis. Additionally, IOX5 (50 μM; 24-96 hours) increases the expression of the BNIP3 protein in AML and THP-1 cells. |
| In vivo | IOX5 (30 mg/kg; intraperitoneal injection; twice daily; two weeks) exhibits anti-leukemic activity in mice without affecting normal hematopoietic function. |
| Formula | C17H19F3N4O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.